Aseptice Conference Banner

Keynote Sessions

Print this page         

William Wiederseim, President & CEO, PharmaBioSource, Inc., USA

The Market for Parenteral Products and Facilities

Parenteral dosage forms are one of the costliest ways to deliver drugs. The market for parenteral delivery is growing at 10% per year making it one of the key drivers of cost to deliver new innovation.

The transaction market for parenteral facilities assets is an “unilluminated market”. PharmaBioSource will shed some light on the market exposing opportunities to reduce costs and product time to market through the acquisition of existing parenteral assets.

Udo Vetter, Managing Director, UV-Cap GmbH & Co KG, Germany

Why Vaccines Are No Longer in Vials

Mark Von Stwolinski, VP Architectural Services, CRB Consulting Engineers, Inc., USA

Special Presentation on the ISPE Sterile Guide by Co-Author

Host Sponsor